BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11553452)

  • 1. Activation induced by pore-forming bacterial toxins.
    Jeyaseelan S
    Trends Microbiol; 2001 Sep; 9(9):416-17. PubMed ID: 11553452
    [No Abstract]   [Full Text] [Related]  

  • 2. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins.
    Bhakdi S; Bayley H; Valeva A; Walev I; Walker B; Kehoe M; Palmer M
    Arch Microbiol; 1996 Feb; 165(2):73-9. PubMed ID: 8593102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage to cell membranes by pore-forming bacterial cytolysins.
    Bhakdi S; Tranum-Jensen J
    Prog Allergy; 1988; 40():1-43. PubMed ID: 2451254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic applications of pore-forming lytic toxins: potential use of Escherichia coli alpha-hemolysin].
    Herlax V; Bakas LS
    Medicina (B Aires); 2002; 62(1):66-72. PubMed ID: 11965855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal pore-forming toxins.
    Prévost G; Mourey L; Colin DA; Menestrina G
    Curr Top Microbiol Immunol; 2001; 257():53-83. PubMed ID: 11417122
    [No Abstract]   [Full Text] [Related]  

  • 6. The family of Serratia type pore forming toxins.
    Hertle R
    Curr Protein Pept Sci; 2005 Aug; 6(4):313-25. PubMed ID: 16101433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterobacterial hemolysins: activation, secretion and pore formation.
    Braun V; Schönherr R; Hobbie S
    Trends Microbiol; 1993 Sep; 1(6):211-6. PubMed ID: 8137117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerolysin from Aeromonas hydrophila and related toxins.
    Fivaz M; Abrami L; Tsitrin Y; van der Goot FG
    Curr Top Microbiol Immunol; 2001; 257():35-52. PubMed ID: 11417121
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrinsic repair protects cells from pore-forming toxins by microvesicle shedding.
    Romero M; Keyel M; Shi G; Bhattacharjee P; Roth R; Heuser JE; Keyel PA
    Cell Death Differ; 2017 May; 24(5):798-808. PubMed ID: 28186501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, maturation and export of the E. coli hemolysin.
    Koronakis V; Hughes C
    Med Microbiol Immunol; 1996 Sep; 185(2):65-71. PubMed ID: 8884737
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial hemolysins and leukotoxins affect target cells by forming large exogenous pores into their plasma membrane: Escherichia coli hemolysin A as a case example.
    Menestrina G; Dalla Serra M; Pederzolli C; Bregante M; Gambale F
    Biosci Rep; 1995 Dec; 15(6):543-51. PubMed ID: 9156583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus α-toxin: small pore, large consequences.
    von Hoven G; Qin Q; Neukirch C; Husmann M; Hellmann N
    Biol Chem; 2019 Sep; 400(10):1261-1276. PubMed ID: 30951494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of Staphylococcus aureus gamma-hemolysin into a pore-forming ring-shaped complex on the surface of human erythrocytes.
    Sugawara N; Tomita T; Kamio Y
    FEBS Lett; 1997 Jun; 410(2-3):333-7. PubMed ID: 9237657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin.
    Wai SN; Lindmark B; Söderblom T; Takade A; Westermark M; Oscarsson J; Jass J; Richter-Dahlfors A; Mizunoe Y; Uhlin BE
    Cell; 2003 Oct; 115(1):25-35. PubMed ID: 14532000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between RTX toxins and target cells.
    Lally ET; Hill RB; Kieba IR; Korostoff J
    Trends Microbiol; 1999 Sep; 7(9):356-61. PubMed ID: 10470043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol specificity of some heptameric beta-barrel pore-forming bacterial toxins: structural and functional aspects.
    Harris JR; Palmer M
    Subcell Biochem; 2010; 51():579-96. PubMed ID: 20213559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LLO-mediated Cell Resealing System for Analyzing Intracellular Activity of Membrane-impermeable Biopharmaceuticals of Mid-sized Molecular Weight.
    Murakami M; Kano F; Murata M
    Sci Rep; 2018 Jan; 8(1):1946. PubMed ID: 29386585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli.
    Law D
    J Appl Microbiol; 2000 May; 88(5):729-45. PubMed ID: 10792533
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation.
    Portman JL; Huang Q; Reniere ML; Iavarone AT; Portnoy DA
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability increase induced by Escherichia coli hemolysin A in human macrophages is due to the formation of ionic pores: a patch clamp characterization.
    Menestrina G; Pederzolli C; Dalla Serra M; Bregante M; Gambale F
    J Membr Biol; 1996 Jan; 149(2):113-21. PubMed ID: 8834118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.